LeMaitre Vascular Inc
NASDAQ:LMAT
Relative Value
The Relative Value of one
LMAT
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 108.06 USD,
LeMaitre Vascular Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
LMAT Competitors Multiples
LeMaitre Vascular Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
LeMaitre Vascular Inc
NASDAQ:LMAT
|
2.5B USD | 9.5 | 41 | 27.8 | 32.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
187.6B USD | 4.2 | 28.8 | 16.5 | 22.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
167.7B USD | 16.7 | 58.7 | 44.5 | 54.7 | |
| US |
|
Stryker Corp
NYSE:SYK
|
128.8B USD | 5.1 | 39.7 | 20.3 | 24.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.8B USD | 3.2 | 24.2 | 13.4 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
102.5B USD | 5.1 | 35.4 | 20.8 | 27.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.9B EUR | 1.9 | 20.7 | 11.5 | 16.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.5B USD | 7.8 | 44.3 | 24.3 | 26.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.4B USD | 2.1 | 25.8 | 10.2 | 17.2 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.7B USD | 10.6 | 43.2 | 30.7 | 34 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.6B USD | 6.2 | 22.6 | 15.9 | 17.7 |